Overview

The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

Status:
COMPLETED
Trial end date:
2025-05-08
Target enrollment:
Participant gender:
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.
Phase:
PHASE1
Details
Lead Sponsor:
Addpharma Inc.